Gene · 10057
Papers1,907
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 1,907
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Gene-level dissection of chromosome 3q locus amplification in squamous cell carcinoma of the lung using the nCounter assay. | Thorac Cancer | 2023 | 37469197 | PubTator, text mining | PubMed |
| Review of 5-FU resistance mechanisms in colorectal cancer: clinical significance of attenuated on-target effects. | Cancer Drug Resist | 2023 | 37457133 | PubTator, text mining | PubMed |
| Editor's Note: Reduced miR-128 in Breast Tumor-Initiating Cells Induces Chemotherapeutic Resistance via Bmi-1 and ABCC5. | Clin Cancer Res | 2023 | 37449361 | PubTator, text mining | PubMed |
| It Takes Two to Tango! Protein-Protein Interactions behind cAMP-Mediated CFTR Regulation. | Int J Mol Sci | 2023 | 37445715 | PubTator, text mining | PubMed |
| Galectin-1-mediated MET/AXL signaling enhances sorafenib resistance in hepatocellular carcinoma by escaping ferroptosis. | Aging (Albany NY) | 2023 | 37433225 | PubTator, text mining | PubMed |
| Natural Nrf2 Inhibitors: A Review of Their Potential for Cancer Treatment. | Int J Biol Sci | 2023 | 37416770 | PubTator, text mining | PubMed |
| MRI-based breast cancer radiogenomics using RNA profiling: association with subtypes in a single-center prospective study. | Breast Cancer Res | 2023 | 37391754 | PubTator, text mining | PubMed |
| Reprohackathons: promoting reproducibility in bioinformatics through training. | Bioinformatics | 2023 | 37387150 | PubTator, text mining | PubMed |
| Machine learning identifies ferroptosis-related genes as potential diagnostic biomarkers for osteoarthritis. | Front Endocrinol (Lausanne) | 2023 | 37378023 | PubTator, text mining | PubMed |
| Genetics: A Starting Point for the Prevention and the Treatment of Obesity. | Nutrients | 2023 | 37375686 | PubTator, text mining | PubMed |
| Role of Intracellular Drug Disposition in the Response of Acute Myeloid Leukemia to Cytarabine and Idarubicin Induction Chemotherapy. | Cancers (Basel) | 2023 | 37370755 | PubTator, text mining | PubMed |
| The Alternating Access Mechanism in Mammalian Multidrug Resistance Transporters and Their Bacterial Homologs. | Membranes (Basel) | 2023 | 37367772 | PubTator, text mining | PubMed |
| Pharmacokinetic interaction of voriconazole and clarithromycin in Pakistani healthy male volunteers: a single dose, randomized, crossover, open-label study. | Front Pharmacol | 2023 | 37361220 | PubTator, text mining | PubMed |
| Potential herb‒drug interactions between anti-COVID-19 drugs and traditional Chinese medicine. | Acta Pharm Sin B | 2023 | 37360014 | PubTator, text mining | PubMed |
| Mechanism of sorafenib resistance associated with ferroptosis in HCC. | Front Pharmacol | 2023 | 37351514 | PubTator, text mining | PubMed |
| Evaluating the effect of acute diesel exhaust particle exposure on P-glycoprotein efflux transporter in the blood-brain barrier co-cultured with microglia. | Curr Res Toxicol | 2023 | 37332622 | PubTator, text mining | PubMed |
| CD44 is a potential immunotherapeutic target and affects macrophage infiltration leading to poor prognosis. | Sci Rep | 2023 | 37316699 | PubTator, text mining | PubMed |
| Methotrexate Provokes Disparate Folate Metabolism Gene Expression and Alternative Splicing in Ex Vivo Monocytes and GM-CSF- and M-CSF-Polarized Macrophages. | Int J Mol Sci | 2023 | 37298590 | PubTator, text mining | PubMed |
| Prognostic Factors for Cardiotoxicity among Children with Cancer: Definition, Causes, and Diagnosis with Omics Technologies. | Diagnostics (Basel) | 2023 | 37296716 | PubTator, text mining | PubMed |
| Exercise-induced hypothalamic neuroplasticity: Implications for energy and glucose metabolism. | Mol Metab | 2023 | 37268247 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10057/papers?page=7